Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-12-08 Thompson Peter A. Director Conversion · Series A Preferred Stock −12,857,142 0
2020-12-08 Thompson Peter A. Director Conversion · Series B Preferred Stock −9,259,259 0
2020-12-08 Thompson Peter A. Director Conversion · Series C Preferred Stock −3,918,279 0
2020-12-08 ORBIMED ADVISORS LLC Director Purchase +238,100 $21.00 $5.0M 507,423
2020-12-08 ORBIMED ADVISORS LLC Director Conversion +3,462,737 3,970,160
2020-12-08 ORBIMED ADVISORS LLC Director Conversion +2,493,741 6,463,901
2020-12-08 ORBIMED ADVISORS LLC Director Conversion +1,055,287 7,519,188
2020-12-08 ORBIMED ADVISORS LLC Director Purchase +952,377 $21.00 $20.0M 952,377
2020-12-08 ORBIMED ADVISORS LLC Director Conversion · Series A Preferred Stock −12,857,142 0
2020-12-08 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −9,259,259 0
2020-12-08 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −3,918,279 0
2020-12-03 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +38,270 38,270
2020-12-03 Odegard Valerie President and CSO Grant or award · Stock Option (right to buy) +364,904 364,904
2020-12-03 Shawver Laura Chief Executive Officer Grant or award · Stock Option (right to buy) +562,631 562,631
2020-12-03 ROOT JONATHAN D Director Grant or award · Stock Option (right to buy) +38,270 38,270
2020-12-03 Powell Andrew Kenneth William Director Grant or award · Stock Option (right to buy) +21,009 21,009
2020-12-03 Piazza Jonathan Chief Financial Officer Grant or award · Stock Option (right to buy) +74,730 74,730
2020-12-03 Islam Saqib Director Grant or award · Stock Option (right to buy) +69,753 69,753
2020-12-03 Hunder Naomi Chief Medical Officer Grant or award · Stock Option (right to buy) +231,071 231,071
2020-12-03 HERSHBERG ROBERT Director Grant or award · Stock Option (right to buy) +73,251 73,251

Page 30 of 31 · 602 trades